FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2091255480> ?p ?o ?g. }

• W2091255480 endingPage "2055" @default.
• W2091255480 startingPage "2050" @default.
• W2091255480 abstract "Cytotoxic chemotherapy has an evolving role in the management of metastatic cancer of the bladder and urinary tract. The most responsive of these tumors are transitional cell carcinomas. Standard single agents (e.g., methotrexate, doxorubicin, mitomycin, ifosfamide, vinblastine, and cisplatin) have produced objective response rates of 15–25% and combination chemotherapy has resulted in objective regression in 40–75% of cases. The taxanes and gemcitabine are now being incorporated into combination regimens because they have activity against this disease, both in previously treated and untreated patients. In previously untreated patients, regimens incorporating gemcitabine and paclitaxel and a platinum complex, with or without ifosfamide or doxorubicin, produce median survival periods of 15–20 months. Contemporary experience with the methotrexate/vinblastine/doxorubicin/cisplatin regimen yields a median survival period of 18 months. Traditional cytotoxic regimens have been ineffective in the management of adenocarcinoma and squamous cell carcinoma of the bladder. However, regimens predicated on the taxanes and gemcitabine yield response rates of 30–40%, which may translate into improved survival. Nevertheless, stage migration may produce the semblance of improved survival, which may reflect reduced tumor burden (via reclassification) and case selection. Because historically controlled comparisons may introduce errors from case selection bias, stage migration, differences in duration of follow-up, and the evolution of supportive care, it is essential to validate the role of new agents in well structured, randomized clinical trials. Cancer 2003;97(8 Suppl):2050–5. © 2003 American Cancer Society. DOI 10.1002/cncr.11280" @default.
• W2091255480 created "2016-06-24" @default.
• W2091255480 creator A5055990171 @default.
• W2091255480 date "2003-04-01" @default.
• W2091255480 modified "2023-10-18" @default.
• W2091255480 title "Progress in the chemotherapy of metastatic cancer of the urinary tract" @default.
• W2091255480 cites W1802318902 @default.
• W2091255480 cites W1820014750 @default.
• W2091255480 cites W1827428051 @default.
• W2091255480 cites W1840050571 @default.
• W2091255480 cites W1855374361 @default.
• W2091255480 cites W1858135205 @default.
• W2091255480 cites W1862964936 @default.
• W2091255480 cites W1867318780 @default.
• W2091255480 cites W1893740135 @default.
• W2091255480 cites W1936664258 @default.
• W2091255480 cites W1939723756 @default.
• W2091255480 cites W1941332786 @default.
• W2091255480 cites W1945195571 @default.
• W2091255480 cites W1957837469 @default.
• W2091255480 cites W1967171779 @default.
• W2091255480 cites W1968487988 @default.
• W2091255480 cites W1973949121 @default.
• W2091255480 cites W2006994933 @default.
• W2091255480 cites W2027887565 @default.
• W2091255480 cites W2039082157 @default.
• W2091255480 cites W2047108938 @default.
• W2091255480 cites W2083696180 @default.
• W2091255480 cites W2101562875 @default.
• W2091255480 cites W2103133513 @default.
• W2091255480 cites W2119211684 @default.
• W2091255480 cites W2168812605 @default.
• W2091255480 cites W2169421598 @default.
• W2091255480 cites W2222153390 @default.
• W2091255480 cites W2239637784 @default.
• W2091255480 cites W2240844634 @default.
• W2091255480 cites W2255768778 @default.
• W2091255480 cites W2261090639 @default.
• W2091255480 cites W2268861790 @default.
• W2091255480 cites W2278983923 @default.
• W2091255480 cites W2314635417 @default.
• W2091255480 cites W2336213711 @default.
• W2091255480 cites W2336338804 @default.
• W2091255480 cites W2397594606 @default.
• W2091255480 cites W4231378490 @default.
• W2091255480 doi "https://doi.org/10.1002/cncr.11280" @default.
• W2091255480 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12673696" @default.
• W2091255480 hasPublicationYear "2003" @default.
• W2091255480 type Work @default.
• W2091255480 sameAs 2091255480 @default.
• W2091255480 citedByCount "26" @default.
• W2091255480 countsByYear W20912554802013 @default.
• W2091255480 countsByYear W20912554802014 @default.
• W2091255480 countsByYear W20912554802015 @default.
• W2091255480 countsByYear W20912554802016 @default.
• W2091255480 countsByYear W20912554802018 @default.
• W2091255480 countsByYear W20912554802019 @default.
• W2091255480 crossrefType "journal-article" @default.
• W2091255480 hasAuthorship W2091255480A5055990171 @default.
• W2091255480 hasBestOaLocation W20912554801 @default.
• W2091255480 hasConcept C121608353 @default.
• W2091255480 hasConcept C126322002 @default.
• W2091255480 hasConcept C126894567 @default.
• W2091255480 hasConcept C143998085 @default.
• W2091255480 hasConcept C2776694085 @default.
• W2091255480 hasConcept C2777132456 @default.
• W2091255480 hasConcept C2777506904 @default.
• W2091255480 hasConcept C2778065480 @default.
• W2091255480 hasConcept C2778239845 @default.
• W2091255480 hasConcept C2780258809 @default.
• W2091255480 hasConcept C2780352672 @default.
• W2091255480 hasConcept C2781303535 @default.
• W2091255480 hasConcept C2781413609 @default.
• W2091255480 hasConcept C3019864225 @default.
• W2091255480 hasConcept C71924100 @default.
• W2091255480 hasConceptScore W2091255480C121608353 @default.
• W2091255480 hasConceptScore W2091255480C126322002 @default.
• W2091255480 hasConceptScore W2091255480C126894567 @default.
• W2091255480 hasConceptScore W2091255480C143998085 @default.
• W2091255480 hasConceptScore W2091255480C2776694085 @default.
• W2091255480 hasConceptScore W2091255480C2777132456 @default.
• W2091255480 hasConceptScore W2091255480C2777506904 @default.
• W2091255480 hasConceptScore W2091255480C2778065480 @default.
• W2091255480 hasConceptScore W2091255480C2778239845 @default.
• W2091255480 hasConceptScore W2091255480C2780258809 @default.
• W2091255480 hasConceptScore W2091255480C2780352672 @default.
• W2091255480 hasConceptScore W2091255480C2781303535 @default.
• W2091255480 hasConceptScore W2091255480C2781413609 @default.
• W2091255480 hasConceptScore W2091255480C3019864225 @default.
• W2091255480 hasConceptScore W2091255480C71924100 @default.
• W2091255480 hasIssue "S8" @default.
• W2091255480 hasLocation W20912554801 @default.
• W2091255480 hasLocation W20912554802 @default.
• W2091255480 hasOpenAccess W2091255480 @default.
• W2091255480 hasPrimaryLocation W20912554801 @default.
• W2091255480 hasRelatedWork W1998553286 @default.
• W2091255480 hasRelatedWork W2029242108 @default.
• W2091255480 hasRelatedWork W2037022485 @default.

• next